Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company for $250 Million
Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company for $250 Million Read Post »
Includes all shareholder-related actions such as dividends, bonus issues, stock splits, buybacks, and rights issues. These announcements directly impact shareholder value and stock price adjustments.